FDA Approved Dovato – A New Combination Pill To Treat HIV

New drug Dovato for HIV

The Food and Drug Administration (FDA) lately declared the approval of Dovato, the first complete two-drug HIV treatment program for folks that previously haven’t been on antiretroviral treatment.

The new drug is for people that don’t have any known or suspected resistance to the treatment, based on a press release trusted source.  Currently, the treatment for HIV-positive people who haven’t been receiving antiretroviral therapy has been a three-drug regimen.

Why is Dovato Important?

It provides the potential for these individuals to take their two-drug regimen in one particular tablet. ViiV Healthcare developed the drug.

“Having a drug-sparing treatment available that uses fewer drugs is beneficial to patients who may have issues taking multiple medications over a long period of time,” said Dr. Debra Birnkrant, director of the FDA’s division of antiviral products, in the release.

However, this isn’t the first HIV only two-drug treatment ever invented.…

The Pros And Cons Of Workplace HIV Testing Measures

Workplace HIV Testing

Workplace drug testing is a tool that many companies  use for hiring new employees and to ensure the safety of workers and reputation of the business.

A worker with a drug habit may be an unreliable, unsafe worker. While many have come to accept this workplace drug testing as the norm, there are concerns over the ethics and practices.

Some employees may feel unfairly singled out from the rest of the workforce and fear discrimination. If this is the current state for workers with recreational drug habits, the problem is worse for HIV-positive employees.